D1 dopamine receptor activation is necessary for the induction of sensitization by amphetamine in the ventral tegmental area

Journal of Neuroscience

Volumn 16, Issue 7, 1996, Pages 2411-2420

  Vezina, Paul ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

amphetamine; dopamine; locomotion; nucleus accumbens; sensitization; ventral tegmental area

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AMPHETAMINE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; ETICLOPRIDE; SPIPERONE; SULPIRIDE; AMPHETAMINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOLOGY; INTRACEREBRAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MICRODIALYSIS; MICROINJECTION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR BLOCKING; SENSITIZATION; SUBCUTANEOUS DRUG ADMINISTRATION; VENTRAL TEGMENTUM; ANIMAL; ANIMAL BEHAVIOR; DENDRITE; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; PHYSIOLOGY; SENSITIVITY AND SPECIFICITY; SPRAGUE DAWLEY RAT; ULTRASTRUCTURE;

AMPHETAMINES; ANIMALS; BEHAVIOR, ANIMAL; DENDRITES; DOPAMINE; LOCOMOTION; MALE; MICRODIALYSIS; MICROINJECTIONS; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; SENSITIVITY AND SPECIFICITY; VENTRAL TEGMENTAL AREA;

EID: 0029664435     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.16-07-02411.1996     Document Type: Article

References (60)

1. 1 receptor antagonists Eur J Pharmacol 219:45-52.
2. Beitner-Johnson D, Guitart X, Nestler EJ (1992) Neurofilament proteins and the mesolimbic dopamine system: common regulation by chronic morphine and chronic cocaine in the rat ventral tesmental area. J Neurosci 12:2165-2176.
3. Bischoff S, Heinrich M, Sonntag JM, Krauss J (1986) The D-1 dopamine receptor antagonist SCH 23390 also interacts potently with brain serotonin (5-HT2) receptors. Eur J Pharmacol 129:367-370.
4. Bonhomme N, Cador M, Stinus L, Le Moal M, Spampinato U (1995) Short- and long-term changes in dopamine and serotonin receptor binding sites in amphetamine-sensitized rats: a quantitative autoradiographic study. Brain Res 675:215-223.
5. 2 receptor mRNA. Brain Res 564:203-219.
6. Cador M, Bjijou Y, Stinus L (1995) Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine. Neuroscience 65:385-395.
7. Cameron DL, Williams JT (1993) Dopamine D1 receptors facilitate transmitter release. Nature 366:344-347.
8. Castaneda E, Becker JB, Robinson TE (1988) The long-term effects of repeated amphetamine treatment in vitro. Life Sci 42:2447-2456.
9. Criswell HE, Mueller RA, Breese GR (1990) Long-term D-1 dopamine receptor sensitization in neonatal 6-OHDA-lesioned rats is blocked by an NMDA antagonist. Brain Res 512:284-290.
10. Deutch AY, Bourdelais AJ, Zahm DS (1993) The nucleus accumbens core and shell: accumbal compartments and their functional attributes. In: Limbic motor circuits and neuropsychiatry (Kalivas PW, Barnes CD, eds), pp 45-88. Boca Raton: CRC.
11. Di Chiara G (1993) Searching for the hidden order in chaos. Commentary on Kalivas et al. "The pharmacology and neural circuitry of sensitization to psychostimulants." Behav Pharmacol 4:335-337.
12. Dougherty Jr GG, Ellinwood Jr EH (1981) Chronic D-amphetamine in nucleus accumbens: lack of tolerance or reverse tolerance of locomotor activity. Life Sci 28:2295-2298.
13. Drew KL, Glick SD (1990) Role of D-1 and D-2 receptor stimulation in sensitization to amphetamine-induced circling behavior and in expression and extinction of the Pavaovian conditioned response. Psychopharmacology (Berl) 101:465-471.
14. Hamamura T, Akiyama K, Akimoto K, Kaskira K, Okumura K, Ujike H, Otsuki S (1991) Co-administration of either a selective D-1 or D-2 dopamine antagonist with methamphetamine prevents methamphetamine-induced behavioral sensitization and neurochemical change, studied by in vivo intracerebral dialysis. Brain Res 546:40-46.
15. Henry DJ, White FJ (1991) Repeated cocaine administration causes persistent enhancement of D1 dopamine receptor sensitivity within the rat nucleus accumbens. J Pharmacol Exp Ther 258:882-890.
16. Hooks MS, Jones GH, Liem BJ, Justice Jr JB (1992) Sensitization and individual differences to intraperitoneal amphetamine, cocaine or caffeine following repeated intracranial amphetamine infusions. Pharmacol Biochem Behav 43:815-823.
17. Jeziorski M, White FJ (1995) Dopamine receptor antagonists prevent expression, but not development, of morphine sensitization. Eur J Pharmacol 275:235-244.
18. Kalivas PW (1993) Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res Rev 18:75-113.
19. Kalivas PW, Alesdatter JE (1993) Involvement of NMDA receptor stimulation in the VTA and amygdala in behavioral sensitization to cocaine. J Pharmacol Exp Ther 267:486-495.
20. Kalivas PW, Duffy P (1993a) Time course of extracellular dopamine and behavioral sensitization to cocaine. II. Dopamine perikarya. J Neurosci 13:276-284.
21. Kalivas PW, Duffy P (1993b) Time course of extracellular dopamine and behavioral sensitization to cocaine: I. Dopamine axon terminals. J Neurosci 13:266-275.
22. 1 receptors modulate glutamate transmission in the ventral tegmental area. J Neurosci 15:5379-5388.
23. Kalivas PW, Stewart J (1991) Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Rev 16:223-224.
24. Kalivas PW, Weber B (1988) Amphetamine injected into the A10 dopamine region sensitizes rats to peripheral amphetamine and cocaine. J Pharmacoi Exp Ther 245:1095-1102.
25. Kirk RE (1968) Experimental design: procedures for the behavioral sciences. Pacific Grove, CA: Brooks/Cole.
26. Kolta MG, Shreve P, Desouza V, Uretsky NJ (1985) Time course of the development of the enhanced behavioral and biochemical responses to amphetamine after pretreatment with amphetamine. Neuropharmacology 24:823-829.
27. Kuczenski R (1983) Biochemical actions of amphetamine and other stimulants. In: Stimulants: neurochemical, behavioral and clinical perspectives (Creese I, ed). pp 31-61. New York: Raven.
28. Kuczenski R, Segal DS (1989) Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis. J Neurosci 9:2051-2065.
29. Mansour A, Meador-Woodruff JH, Bunzow JR, Civelli O, Akil H, Watson SJ (1990) Localization of dopamine D-2 receptor mRNA and D-1 and D-2 receptor binding in the rat brain and pituitary, an in situ hybridization-receptor autoradiographic analysis. J Neurosci 10:2587-2600.
30. Mansour A, Meador-Woodruff JH, Zhou Q, Civelli O, Akil H, Watson SJ, Jr (1992) A comparison of D1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques. Neuroscience 46:959-971.
31. McQuade RD, Ford D, Duffy RA, Chipkin RE, Iorio LC, Barnett A (1988) Serotonergic component of SCH 23390: in vitro and in vivo binding analyses. Life Sci 43:1861-1869.
32. Nestler EJ (1992) Molecular mechanisms of drug addiction. J Neurosci 12:2439-2450.
33. 3H]-YM-09151-2. Naunyn Schmiedebergs Arch Pharmacol 329:333-343.
34. Paulson PE, Camp DM, Robinson TE (1991) Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats. Psychopharmacology (Berl) 103:480-492.
35. Paulson PE, Robinson TE (1995) Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: a microdialysis study in behaving rats. Synapse 19:56-65.
36. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. New York: Academic.
37. Pellegrino LJ, Pellegrino AS, Cushman AJ (1979) A stereotaxic atlas of the rat brain. New York: Plenum.
38. Peris J, Boyson SJ, Cass WA, Curella P, Dwoskin IP, Larson G, Lin L-H, Yasuda RP, Sahniser NR (1990) Persistence of neurochemical changes in dopamine systems after repeated cocaine administration. J Pharmacol Exp Ther 253:38-44.
39. Perugini M, Vezina P (1994) Amphetamine administered to the ventral tegmental area sensitizes rats to the locomotor effects of nucleus accumbens amphetamine. J Pharmacol Exp Ther 270:690-696.
40. Robinson TE (1991) The neurobiology of amphetamine psychosis: evidence from studies with an animal model. In: Biological basis of schizophrenic disorders (Nakazawa T, ed), pp 185-201. Tokyo: Japan Scientific Societies.
41. Robinson TE, Becker JB (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res Rev 11:157-198.
42. Robinson TE, Berridge KC (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev 18:247-291.
43. Robinson TE, Whishaw IQ (1988) Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats. Brain Res 450:209-224.
44. Robinson TE, Jurson PA, Bennett JA, Bentgen KM (1988) Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: a microdialysis study in freely moving rats. Brain Res 462:211-222.
45. Seeman P, Grigoriadis D (1987) Dopamine receptors in brain and periphery. Neurochem Int 10:1-25.
46. Segal DS, Kuczenski R (1992a) In vivo microdialysis reveals a diminished amphetamine-induced DA response corresponding to behavioral sensitization produced by repeated amphetamine pretreatment. Brain Res 571:330-337.
47. Segal DS, Kuczenski R (1992b) Repeated cocaine administration induces behavioral sensitization and corresponding decreased extracellular dopamine responses in caudate and accumbens. Brain Res 577:351-355.
48. Sorg BA, Ulibarri C (1995) Application of a protein synthesis inhibitor into the ventral tegmental area, but not the nucleus accumbens, prevents behavioral sensitization to cocaine. Synapse 20:217-224.
49. Steketee JD (1994) Imra-A10 injection of H7 blocks the development of sensitization to cocaine. NeuroReport 6:69-72.
50. Stewart J, Vezina P (1989) Microinjections of SCH-23390 into the ventral tegmental and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systemic amphetamine. Brain Res 495:401-406.
51. Tomiyama K, Noguchi M, Koshikawa N, Kobayashi M (1993) YM-09151-2 but not L-sulpiride induces transient dopamine release in rat striatum via a tetrodotoxin-insensitive mechanism. J Neurochem 60:1690-1695.
52. 1 dopamine receptors in the lateral part of the substantia nigra pars reticulata after subchronic methamphetamine administration. Brain Res 540:159-163.
53. Ujike H, Onoue R, Akiyama K, Hamamura T, Otsuki S (1989) Effects of selective D-1 and D-2 dopamine antagonists on development of methamphetamine-induced behavioral sensitization. Psychopharmacology (Berl) 98:89-92.
54. Vezina P (1993) Amphetamine injected into the ventral tegmental area sensitizes the nucleus accumbens dopaminergic response to systemic amphetamine: an in vivo microdialysis study in the rat. Brain Res 605:332-337.
55. Vezina P, Stewart J (1989) The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine. Brain Res 499:108-120.
56. Vezina P, Stewart J (1990) Amphetamine administered to the ventral tegrnental area but not to the nucleus accumbens sensitizes rats to systemic morphine: lack of conditioned effects. Brain Res 516:99-106.
57. White FJ, Wang RY (1984) Pharmacological characterization of dopamine autoreceptors in the rat ventral tegmental area: microiontophoretic studies. J Pharmacol Exp Ther 231:275-280.
58. White FJ, Hu X-T, Zhang X-F, Wolf ME (1995) Repeated administration of cocaine or amphetamine alters neuronal responses to glutamate in the mesoaccumbens dopamine system. J Pharmacol Exp Ther 273:445-454.
59. Wolf ME, White FJ, Hu X-T (1994) MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine. J Neurosci 14:1735-1745.
60. Wolf ME, White FJ, Nassar R, Brooderson RJ, Khansa MR (1993) Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization. J Pharmacol Exp Ther 264:249-255.